Thiazolidinediones can rapidly activate AMP-activated protein kinase in mammalian tissues

Nathan K LeBrasseur1, Meghan Kelly, Tsu-Shuen Tsao

  • 1Diabetes and Metabolism Research Unit, Boston University School of Medicine, 650 Albany St., X-820, Boston, MA 02118, USA.

Insights

Thiazolidinediones (TZDs) rapidly activate AMP-activated protein kinase (AMPK) in tissues, independent of gene transcription. This acute effect on AMPK is linked to cellular energy changes and improves glucose uptake and fatty acid oxidation.

Area of Science:

  • Molecular Endocrinology
  • Metabolic Regulation
  • Pharmacology

Background:

  • Thiazolidinediones (TZDs) are established insulin-sensitizing agents for type 2 diabetes.
  • Current understanding links TZD efficacy to PPARgamma-mediated adipogenesis and adiponectin release.
  • Adiponectin is known to activate AMP-activated protein kinase (AMPK), a key metabolic regulator.

Purpose of the Study:

  • To investigate the acute effects of TZDs on AMPK activation.
  • To determine if TZD-induced AMPK activation is dependent on PPARgamma-mediated gene transcription.

Main Methods:

  • Incubation of isolated rat EDL muscles with troglitazone.
  • Measurement of phosphorylated AMPK (pAMPK) and phosphorylated ACC (pACC) levels.
  • Assessment of glucose uptake and fatty acid oxidation rates.
  • In vivo studies in rats and experiments with Swiss 3T3 fibroblasts.

Main Results:

  • Short-term troglitazone treatment rapidly increased pAMPK and pACC in isolated muscles.
  • This acute activation correlated with increased glucose uptake and fatty acid oxidation.
  • TZDs also acutely activated AMPK in various tissues in vivo and in cell lines, irrespective of PPARgamma status.

Conclusions:

  • TZDs can acutely activate AMPK within minutes in mammalian tissues.
  • This rapid AMPK activation is associated with altered cellular energy status (AMP:ATP ratio).
  • The mechanism of acute TZD action on AMPK appears independent of PPARgamma-mediated gene transcription.

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
cAMP-dependent Protein Kinase Pathways01:25

cAMP-dependent Protein Kinase Pathways

Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
Oral Hypoglycemic Agents: Biguanides and Glitazones01:26

Oral Hypoglycemic Agents: Biguanides and Glitazones

Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood glucose levels...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Insulin: The Receptor and Signaling Pathways01:28

Insulin: The Receptor and Signaling Pathways

Insulin action is mediated through a receptor tyrosine kinase, akin to the IGF-1 receptor. The number of receptors per cell varies significantly, from 40 on erythrocytes to 300,000 on adipocytes and hepatocytes. The insulin receptor consists of linked α/β subunit dimers, forming a heterotetramer glycoprotein with two extracellular α subunits and two β subunits spanning the membrane. The α subunits inhibit the inherent tyrosine kinase activity of the β subunits, but this inhibition is released...
Dipeptidyl Peptidase 4 Inhibitors01:23

Dipeptidyl Peptidase 4 Inhibitors

Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a significant...